Maria Pokorska-Śpiewak, Anna Dobrzeniecka, & Agnieszka Ogrodnik. (2022). Efficacy and Safety of the Treatment of Chronic Hepatitis C with Sofosbuvir/Ledipasvir in Children Aged 5 to 10 Years with Comorbidities-A Brief Report. MDPI AG.
Chicago Style (17th ed.) CitationMaria Pokorska-Śpiewak, Anna Dobrzeniecka, and Agnieszka Ogrodnik. Efficacy and Safety of the Treatment of Chronic Hepatitis C with Sofosbuvir/Ledipasvir in Children Aged 5 to 10 Years with Comorbidities-A Brief Report. MDPI AG, 2022.
MLA (9th ed.) CitationMaria Pokorska-Śpiewak, et al. Efficacy and Safety of the Treatment of Chronic Hepatitis C with Sofosbuvir/Ledipasvir in Children Aged 5 to 10 Years with Comorbidities-A Brief Report. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.